A change to the Fitzsimons Innovation Community’s master plan in Aurora will allow eight times more residential units to be built on the medical campus.The Aurora City Council on Monday approved an amendment to the general development plan that increases the Fitzsimons Innovation Community residential unit cap from 850 units to 7,266 new units. Changes…
The University of Colorado Cancer Center this year celebrates its 40th anniversary, highlighting significant advances in research and innovations that include new therapies, treatments and insights into cancer prevention. One of the leaders in cell-based immune therapies is CU Cancer Center member Terry Fry, M.D., executive director of the Gates Institute, a translational research institute…
A new approach for gene editing will get its shot in a common and chronic autoimmune disorder. Rheumatoid arthritis is an autoimmune disease that causes pain and swelling in the joints. It affects about one percent of the adult population. With its HLA gene editing approach, RheumaGen believes it can create a one-time cure for…
A startup is developing a new class of treatments for autoimmune diseases leveraging an approach to editing genes in the HLA family, which play a critical role in the immune system. RheumaGen, which spun out from the University of Colorado Anschutz Medical Campus, launched earlier this year with $15 million in Series A funding co-led…
A new study from Livability finds a lot to love along the Front Range, naming Aurora, Loveland, and Colorado Springs to a list of the 100 best places to live in the U.S. “Living in Aurora means residents can take full advantage of the city’s excellent amenities and strong economy,” the site said. “Biotech startups,…
Each quarter the Colorado Real Estate Journal publishes its Healthcare and Life Sciences Quarterly to report on the state of commercial real estate in Colorado. The most recent edition includes an article from Fitzsimons and our leasing partners at CBRE to explore the forecast for life sciences real estate markets in our region, and why…
Aurora’s Fitzsimons Innovation Community is saving lives, literally! It’s home to all kinds of cutting-edge life science companies that are coming up with ways to improve medical technology and patient care. AuroraTV talks with Fitzsimons’ new President and CEO, Kelly Brough, about what lies ahead.
What Aurora officials say is an industrious Fitzsimons Innovation Community could also become a community where scientists don’t just work, but also live and play while exploring bio and life science. “Aurora saw the vision that said this could be home to healthcare, bio and life science center for the state of Colorado, and today,…
Melissa Krebs, Ph.D., CEO and Founder of Community member GelSana, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. This prestigious honor recognizes her pioneering advancements in cell-interactive biomaterials and their clinical translation, particularly in regenerative medicine and drug delivery technologies. Her innovative work is making significant strides…
BNBuilders announced the completion of a new 5,500-square-foot office and lab space for RefinedScience at the Fitzsimons Innovation Community Campus. This modern, functional environment is designed to support scientific innovation and enhance collaboration.